Aquatic Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Aquatic Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,699	Closed	-$504K	–	1333
2026 Q1	$504K	Sell	12,699 -57,056	-82%	-$1.46M	0.01%	753
2025 Q4	$1.74M	Buy	+69,755	New	+$1.77M	0.05%	409

Aquatic Capital Management's CNTA Position: Q2 2026 in Review

Aquatic Capital Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 12,699 shares — an estimated $504K sold.

Aquatic Capital Management first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $1.74M in Q4 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Aquatic Capital Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Aquatic Capital Management sold 12,699 Centessa Pharmaceuticals shares in Q2 2026, an estimated $504K.
Aquatic Capital Management first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Aquatic Capital Management's Centessa Pharmaceuticals position peaked at $1.74M in Q4 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.